![Catherine Martre](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Catherine Martre
Chief Executive Officer at Meletios Therapeutics SAS
Catherine Martre active positions
Companies | Position | Start | End |
---|---|---|---|
Meletios Therapeutics SAS
![]() Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Director/Board Member | - | - |
Chief Executive Officer | 31/12/2020 | - |
Career history of Catherine Martre
Statistics
International
France | 2 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Meletios Therapeutics SAS
![]() Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- Catherine Martre
- Experience